Sheesh, back when I was a more active investor I remember Novavax. Did they ever get any product approved?
If I was still active, I’d consider going short Moderna at some point. One trick pony. This pandemic will pass at some point and then what will they have to sell, other than the CEO’s $4 billion worth of stock and options?
RE: Sheesh, back when I was a more active investor I remember Novavax.
Novavax is MORE than Covid though.
They develop experimental vaccines for Ebola, influenza, respiratory syncytial virus, and other emerging infectious diseases.